Using a neonatal immunostimulant to reduce mortality and increase productivity in poultry farms

Información del proyecto

PROVICOL

Identificador del acuerdo de subvención: 718986

DOI 10.3030/718986

Proyecto cerrado

Fecha de la firma de la CE 17 Febrero 2016

Fecha de inicio 1 Marzo 2016

Fecha de finalización 31 Agosto 2016

Financiado con arreglo a

• SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy

Coste total € 71 429,00

Aportación de la UE € 50 000,00

Coordinado por

VITAMFERO SA
France

Objetivo

VitamFero, an innovative French SME, is aiming to develop a new approach to protect chickens against infectious diseases during their first weeks of life. The PROVICOL project aims to induce a strong innate immune response in young chickens in order to protect them against a large panel of infectious diseases.

1 - PROVICOL will substantially reduce mortality and morbidity rates in chicken breeding thereby improving the overall breeding production process.
2 - This will also lead to a substantial decrease in the use of antibiotics in breeding establishments.
During the feasibility part (6 months) of PROVICOL, VitamFero will focus the study on technical matters (validation and optimisation of induced innate immune response) and on a business approach. The objective is to confirm, on the basis of previous encouraging results, the wider market opportunity for this product by conducting an economic feasibility study and elaborating a business plan in order to prepare for its marketing. This feasibility study will also validate the market strategy deployment and will improve the business impact of the project (pharmaco-economic study over 3 countries).

The PROVICOL project will generate an expected turnover of 426 million € (127millions € for VitamFero) within 10 years. Provicol is a key project for VitamFero and will act as a lever for the growth of the company, especially for an international commercial deployment.

Ámbito científico

• social sciences › sociology › demography › mortality
• medical and health sciences › health sciences › infectious diseases
• medical and health sciences › basic medicine › immunology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance › antibiotic resistance

Programa(s)

• H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Tema(s)

• SFS-08-2015-1 - Resource-efficient eco-innovative food production and processing

Convocatoria de propuestas

H2020-SMEInst-2014-2015

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SMEINST-1-2015

Régimen de financiación

SME-1 - SME instrument phase 1

Coordinador

VITAMFERO SA

• Aportación neta de la UEn: € 50 000,00
• Dirección: RUE ANDRE LE NOTRE 8 ANGERS TECHNOPOLE ; 49000 ANGERS ; Francia
• Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí:
  Región
  Pays de la Loire › Pays de la Loire › Maine-et-Loire
• Región: Pays de la Loire › Pays de la Loire › Maine-et-Loire
• Tipo de actividad: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Coste total: € 71 429,00